Market Overview

Recap: TELA Bio Q3 Earnings


Shares of TELA Bio (NASDAQ:TELA) were flat after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share increased 97.65% over the past year to ($0.53), which missed the estimate of ($0.49).

Revenue of $5,313,000 higher by 33.73% year over year, which beat the estimate of $4,580,000.


Earnings guidance hasn't been issued by the company for now.

TELA Bio hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Nov 11, 2020

Time: 04:30 PM

ET Webcast URL:


Company's 52-week high was at $23.55

Company's 52-week low was at $5.25

Price action over last quarter: Up 18.62%

Company Description

TELA Bio Inc is a United States-based medical technology company. It is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery.


Related Articles (TELA)

View Comments and Join the Discussion!

Posted-In: Earnings